Do Uterine Polyps Grow Back After Removal?
Having gone through a polyp removal, it's natural to ask whether it could all happen again. The distinction that matters is between regrowth and new growth.
Short answer. A properly removed polyp doesn't grow back — but some women form new polyps over time. The distinction matters: the original, once fully removed, is gone. What can happen is that the same tendency which produced the first polyp produces another, especially where hormonal influences persist. Recurrence isn't universal, and it isn't a sign the first removal failed. New symptoms later simply warrant reassessment, not alarm.
Regrowth versus new growth
This is the key distinction. When a polyp is completely removed during a hysteroscopic uterine polyp removal, that specific polyp is gone and does not regrow. What some women experience is the formation of entirely new polyps over time — not the old one returning, but the same underlying tendency producing another. Separating these two ideas removes a common worry: a new polyp years later doesn't mean the original procedure failed; it means a new one has formed, which is a different thing.
Source: ACOG — endometrial polyps.
Who is more prone to new polyps
Recurrence is not random; certain factors make new polyps more likely.
| Factor | Effect on recurrence |
|---|---|
| Ongoing hormonal influences | Can favor new polyp formation |
| A history of multiple polyps | Suggests a stronger tendency |
| Certain medications | Some are associated with polyps |
| Individual variation | Many women never form another |
Learn more: Hysteroscopic Polypectomy: What Happens During Removal
Source: NHS — womb polyps: recurrence.
What it means for follow-up
The practical upshot is simple: you don’t need to live expecting recurrence, but you should take new symptoms seriously if they arise. Because a fully removed polyp doesn’t regrow, no routine surveillance is usually needed after an uncomplicated removal. But if abnormal bleeding returns later, it’s worth being reassessed — not assuming the old polyp came back, but checking whether a new one has formed. That measured approach avoids both needless worry and missing a genuinely new problem.
| Situation | Approach |
|---|---|
| Uncomplicated removal, no symptoms | Usually no routine surveillance |
| New abnormal bleeding later | Get reassessed |
| History of multiple polyps | May warrant closer follow-up |
| Overall | Take new symptoms seriously, don't assume |
Patients also ask: Uterine Polyps and Spotting Between Periods
At our clinic in Türkiye, we draw the line between regrowth and new growth: the polyp we remove is gone for good, but some women form new ones — so we don't expect recurrence, we simply take any new bleeding seriously if it appears.
Second opinion. If you've had a polyp removed and are worried about recurrence, you can request an second opinion on a uterine polyp.
What the recurrence numbers look like
Across follow-up studies, new polyps appear after polypectomy in a meaningful minority — figures commonly fall in the 15–40% range over several years, with the spread explained by follow-up length, how hard studies looked, and the populations studied. Crucially, most of these are genuinely new polyps arising elsewhere in a polyp-prone lining, not the removed polyp returning: complete hysteroscopic removal with the base makes true same-site regrowth uncommon.
The practical translation: one polyp marks you as someone whose endometrium makes polyps, not as someone whose surgery failed. That reframing matters, because it shifts the response from doubting the procedure toward sensibly watching the lining over the years.
Reducing the odds where they can be reduced
Some drivers of polyp formation are fixed — age, genetics — but others move. Tamoxifen therapy is the classic pharmacological driver, and women taking it warrant tailored gynecologic surveillance rather than standard advice. Obesity raises circulating estrogen and with it polyp risk, giving weight management a quiet second dividend. Chronic unopposed estrogen states, including some hormone therapy regimens, belong on the same reviewable list.
For women needing contraception or bleeding control anyway, the levonorgestrel IUD appears to suppress polyp formation as a side benefit — worth weighing when choices are otherwise equal. None of these guarantees a polyp-free future; together they bend the probabilities in the only direction available.
Living sensibly with a polyp-prone lining
The long-term posture is alertness without anxiety. No fixed scanning schedule is required after removal of a benign polyp in most women — symptoms are the surveillance system. Know your two signals: bleeding between periods or unusually heavy cycles premenopausally, and any bleeding whatsoever after menopause. Either one earns an ultrasound; neither means a polyp is certain, only that looking is warranted.
Keep your pathology report and procedure note where you can find them — future clinicians will calibrate their response to your history. And hold the base rate in mind on anxious days: even in the higher-recurrence groups, the majority of women never need a second polypectomy, and those who do face the same brief, effective procedure the first one was.
Frequently Asked Questions
New polyps appear in roughly 15–40% of women over several years of follow-up — mostly genuinely new growths in a polyp-prone lining rather than the removed polyp returning. The majority never need a second procedure.
Largely yes — hysteroscopic removal including the base makes true same-site regrowth uncommon. Historical 'recurrences' often traced to blind techniques that left fragments behind, which modern direct-vision removal avoids.
Polyp formation reflects the lining's hormonal environment and individual susceptibility — estrogen exposure, age, weight, and drugs like tamoxifen all feed it. One polyp signals a tendency, and tendencies express themselves over years.
Usually not — symptom-triggered checking is the standard: intermenstrual or heavy bleeding before menopause, any bleeding after it. Exceptions with scheduled surveillance include tamoxifen users and women with higher-risk pathology.
The movable levers are weight management, reviewing unopposed-estrogen exposures, and — where it suits other needs — a levonorgestrel IUD, which appears to suppress polyp formation. Fixed factors like age simply argue for knowing your warning signs.
No — recurrence does not itself raise malignancy risk, and each polyp is judged on the same criteria: symptoms, size, menopausal status, and its own pathology. A second polypectomy is the same brief procedure the first was.
The distinction I always draw is regrowth versus new growth. The polyp I remove is gone for good — but the tendency that made it can make another. So I don't have women live expecting recurrence; I simply ask them to take new bleeding seriously if it appears, because that's a new question, not the old one returning.
